SCHEMBL4026751

SCHEMBL4026751

CC(=O)OC[C@H]1[C@@H](CO)[C@@H]2O[C@H]1c1cc3c(cc12)OCO3

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.65
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
THRB P10828 1/20 0.44
HPGD P15428 1/20 0.40
TSHR P16473 2/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
LMNA P02545 1/20 0.38
TRIP13 Q15645 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
CYP1A2 P05177 1/20 0.36
HTT P42858 1/20 0.36
CTNNB1 P35222 1/20 0.36
WNT3A P56704 1/20 0.36
MAPK9 P45984 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13661759 1.00 ESR1 (0.65) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13663615 1.00 ESR1 (0.65) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13661744 1.00 ESR1 (0.65) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13663614 0.94 ESR1 (0.57) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13661747 0.94 ESR1 (0.57) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4201936 0.94 ESR1 (0.57) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL4292917 0.84 ESR1 (0.43) ESR1CYP3A4CYP2D6CYP2C19HPGD
SCHEMBL4292914 0.83 ESR1 (0.47) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13747999 0.81 CYP3A4 (0.51) ESR1CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL13661748 0.77 MAPK9 (0.45) ESR1CYP3A4CYP2D6CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150031759-A1 Analogues of (-)Picropodophyllin, Synthesis And Uses Thereof UNIVERSITY OF NEBRASKA - LINCOLN 2015-01-29 US disclosed
US-8859614-B2 Analogues of (−)-picropodophyllin, synthesis and uses thereof University of Nebraska—Lincoln (US) 2014-10-14 US disclosed
US-20090271879-A1 ANALOGUES OF (-)-PICROPODOPHYLLIN, SYNTHESIS AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2009-10-29 US disclosed
WO-2009100349-A1 ANALOGUES OF (-)-PICROPODOPHYLLIN, SYNTHESIS AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2009-08-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150031759-A1 Analogues of (-)Picropodophyllin, Synthesis And Uses Thereof PPOX, HCCS, DHPS ESR1 4401/4885CYP3A4 520/4885CYP2D6 326/4885
US-20090271879-A1 ANALOGUES OF (-)-PICROPODOPHYLLIN, SYNTHESIS AND USES THEREOF PPOX, HCCS, DHPS ESR1 4320/4885CYP3A4 566/4885CYP2D6 302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.